Search
Diazepinomicin
go.drugbank.com/drugs/DB12420InvestigationalDiazepinomicin is a natural product derived from a non-pathogenic micro-organism. … Discovered using Thallion’s DECIPHER technology, diazepinomicin has completed preclinical studies conducted by the National Cancer Institute and Thallion to establish safety and efficacy in animal and
NM-3
go.drugbank.com/drugs/DB12818InvestigationalNM-3 has been used in trials studying the treatment of Neoplasms.
Synonyms: NM-3Anifrolumab
go.drugbank.com/drugs/DB11976ApprovedInvestigationalThree monoclonal antibodies (anifrolumab, [rontalizumab], and [sifalimumab]) that target the type 1 interferon pathway entered clinical trials as potential treatments for systemic lupus erythematosus, but
1-Dodecanol
go.drugbank.com/drugs/DB06894Experimental(From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) … 1-Dodecanol is a saturated 12-carbon fatty alcohol obtained from coconut oil fatty acids. It has a floral odor and is used in detergents, lubricating oils, and pharmaceuticals.
Etazolate
go.drugbank.com/drugs/DB05881InvestigationalEHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.
Benzoctamine
go.drugbank.com/drugs/DB09021ExperimentalIt can be used as a sedative which does not depress the respiratory system, but rather stimulates it.
Synonyms: N-Methyl-9,10-ethanoanthracene-9(10H)-methanamineBrotizolam
go.drugbank.com/drugs/DB09017ApprovedWithdrawnBrotizolam is not approved for sale in the UK, United States or Canada but is sold in the Netherlands, Germany, Spain, Belgium, Austria, Portugal, Israel, Italy and Japan.
Casimiroin
go.drugbank.com/drugs/DB08744ExperimentalCasimiroin is a quinone reductase 2 inhibitor isolated from _Casimiroa edulis_.
Kitasamycin
go.drugbank.com/drugs/DB09309ExperimentalKitasamycin is a macrolide antibiotic derived from <em>Streptomyces kitasatoensis</em>.
Romlusevimab
go.drugbank.com/drugs/DB16494InvestigationalRomlusevimab (BRII-198) was under investigation in clinical trials (NCT04479644 and NCT04691180) to treat COVID-19, focusing on its safety, tolerability, and pharmacokinetics.